Neomend Revenue and Competitors
Estimated Revenue & Valuation
- Neomend's estimated annual revenue is currently $6M per year.
- Neomend's estimated revenue per employee is $251,000
Employee Data
- Neomend has 24 Employees.
- Neomend grew their employee count by -8% last year.
Neomend's People
| Name | Title | Email/Phone |
|---|
Neomend Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $24.1M | 96 | 19% | N/A | N/A |
#2 | $9.5M | 38 | 12% | N/A | N/A |
#3 | $4M | 16 | -11% | N/A | N/A |
#4 | $7.8M | 31 | -3% | N/A | N/A |
#5 | $5M | 20 | -5% | N/A | N/A |
#6 | $49.9M | 199 | -8% | N/A | N/A |
#7 | $16.8M | 67 | -17% | $63.2M | N/A |
#8 | $9.3M | 37 | -7% | N/A | N/A |
#9 | $36.6M | 146 | 22% | N/A | N/A |
#10 | $64.3M | 205 | 3% | $502M | N/A |
What Is Neomend?
Approximately 150,000 lung resections are performed in the United States every year. Intraoperative air leaks are a primary complication of lung surgery which can lead to other complications such as infections, pneumonia and extended hospitalization. Introducing Progel® Pleural Air Leak Sealant, the only commercially available, FDA approved Pleural Air Leak Sealant in the U.S. Following a multi-center clinical study in the U.S., it was shown that Progel PALS led to a statistically significant reduction in both intraoperative air leaks and hospital stay of nearly two days. Our Proprietary Hydrogel Technology Platform enables Neomend to develop advanced Wound Care products for a variety of applications, including wound sealing, prevention of post-surgical adhesions, and site specific, sustained drug delivery.
keywords:N/AN/A
Total Funding
24
Number of Employees
$6M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.8M | 24 | -11% | N/A |
#2 | $2.4M | 24 | N/A | N/A |
#3 | $2.4M | 24 | N/A | N/A |
#4 | $5M | 24 | 26% | $24M |
#5 | $2.2M | 24 | N/A | N/A |
